H.R. 4816 (111th): Food and Drug Administration Improvement Act of 2010

Introduced:

Mar 10, 2010
111th Congress, 2009–2010

Status:
Died in a previous Congress

This bill was introduced on March 10, 2010, in a previous session of Congress, but was not enacted.

Sponsor:

Maurice Hinchey

Representative for New York's 22nd congressional district

Democrat

Text:

Read Text »
Last Updated: Mar 10, 2010
Length: 21 pages

About the bill

Full Title

To amend the Federal Food, Drug, and Cosmetic Act to provide for the deposit in the general fund of the Treasury of fees that are collected from manufacturers of drugs and devices under chapter VII of such Act, to terminate the authority of the Food and Drug Administration to negotiate with the manufacturers on particular uses of the fees, to establish a Center for Postmarket Drug Safety and Effectiveness, to establish additional authorities to ensure the safe and effective use of drugs, and for other purposes.

Read CRS summary >

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

H.R. 2273 (110th) was a previous version of this bill.

Referred to Committee
Last Action: May 10, 2007

What is a bill?

The “H.R.” in “H.R. 4816” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

The bill’s title was written by its sponsor.

History

Introduced
Mar 10, 2010

Details

Cosponsors
none
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.

Votes

There have been no votes related to this bill.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Citation

Click a format for a citation suggestion: